Article Versions Notes

Hogberg HT, Lam A, Ohayon E, Shahbaz MA, Clerbaux L-A, Bal-Price A, Coecke S, Concha R, De Bernardi F, Edrosa E, et al. The Adverse Outcome Pathway Framework Applied to Neurological Symptoms of COVID-19. Cells. 2022; 11(21):3411. https://doi.org/10.3390/cells11213411

Hogberg, Helena T., Ann Lam, Elan Ohayon, Muhammad Ali Shahbaz, Laure-Alix Clerbaux, Anna Bal-Price, Sandra Coecke, Rachel Concha, Francesca De Bernardi, Eizleayne Edrosa, and et al. 2022. "The Adverse Outcome Pathway Framework Applied to Neurological Symptoms of COVID-19" Cells 11, no. 21: 3411. https://doi.org/10.3390/cells11213411

Hogberg, H. T., Lam, A., Ohayon, E., Shahbaz, M. A., Clerbaux, L.-A., Bal-Price, A., Coecke, S., Concha, R., De Bernardi, F., Edrosa, E., Hargreaves, A. J., Kanninen, K. M., Munoz, A., Pistollato, F., Saravanan, S., Garcia-Reyero, N., Wittwehr, C., & Sachana, M. (2022). The Adverse Outcome Pathway Framework Applied to Neurological Symptoms of COVID-19. Cells, 11(21), 3411. https://doi.org/10.3390/cells11213411